Tony Cates joins Cycle Group Holdings Board of Directors

By |2021-10-06T10:39:32+01:00October 6th, 2021|News, Nityr|

Cycle Pharmaceuticals launches SAJAZIR TM (icatibant) Injection, a new treatment option in Hereditary Angioedema (HAE)

By |2021-09-28T11:36:58+01:00September 28th, 2021|News, Nityr|

Cycle Pharmaceuticals Launches Cycle Vita™, a dedicated support platform for rare disease patients

By |2021-09-14T16:56:52+01:00September 10th, 2021|News, Nityr|

Cycle Pharmaceuticals appoints Denise Moody as Chief Operating Officer

By |2021-06-28T11:44:17+01:00June 28th, 2021|Corporate, News|

Cycle Pharmaceuticals appoints Steve McCue as Chief Financial Officer

By |2021-05-25T17:41:24+01:00May 25th, 2021|Corporate, News|

Dr Alejandra Bruna joins Cycle Group Holdings Board of Directors

By |2021-05-17T18:52:30+01:00April 29th, 2021|News, Nityr|

NITYR (nitisinone) Tablets for Tyrosinaemia Type 1 receives Marketing Authorization in New Zealand

By |2021-05-17T18:52:30+01:00March 15th, 2021|News, Nityr|
Go to Top